Newsroom

Displaying 1–10 of 131

June 22, 2026

Seer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics for Multi-Cancer Screening

June 15, 2026

Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign

June 3, 2026

Seer Files Definitive Proxy Materials and Mails Letter to Stockholders

May 29, 2026

Seer Files ITC Complaint Against Nanomics

May 26, 2026

Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026

May 21, 2026

Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group

May 13, 2026

Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook

May 13, 2026

Seer Files Patent Infringement Lawsuit Against Nanomics

May 4, 2026

Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer

April 29, 2026

Seer to Report First Quarter 2026 Financial Results on May 13, 2026

Starting your proteomics research is effortless

Connect with an expert to discuss which path to the full proteome is right for you.

  1. Bring the Proteograph Product Suite in-house
  2. Run a project with
    Seer Technology
    Access Center
  3. Conduct a project with
    a Seer service provider
    or Center of Excellence